New Content  edit
Get The App!

Loading the player...
For an HU-Refractory PV Patient on Ruxolitinib, How Would Your Treat after He/She Progresses to Post-PV MF?
Share URL
Embed Code
Share by Email
Send to social websites
Report this video as inappropriate You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email. Select your reason
Sexual Content Violent or Repulsive Content
Hateful or Abusive Content Harmful Dangerous Acts
Child Abuse Spam
Dr. Srdan Verstovsek, MD Anderson Cancer Center, answers the following question: For an HU-refractory PV patient on ruxolitinib, how would your treat after he/she progresses to post-PV MF?